ZHANG CLINIC
PROTOCOLS
Herb Distribution @
www.hepapro.com



Zhang Clinic
20 E. 46th Street
Suite 1402
New York,  NY 10017

Tel:  (212) 573-9584 
Fax: (212) 573-6045

 
This is a password-protected private information web. Materials presented here is only intended for viewing by Zhang Clinic employees, affiliated professional practitioners and clinic patients.
Hepatitis C
 
Lyme Disease
Hepatitis Peripheral Complications Colitis /Crohn's Disease (Inflammatory Bowel Syndrome)
Non-Alcoholic Steatohepatitis (NASH): Fatty Liver Liver Cirrhosis Related Conditions
Alcoholic Liver Disease  
Auto-Immune Hepatitis
Cholestatic Hepatitis
SinoMed Research Home
About Dr. Zhang
Herbs

ZHANG CLINIC featured again in
Dr. Weil's "Self Healing" newsletter

Click here to read the excerpt

Formula List
AI # 3 Capsule
Allicin Capsule
Artemisia Capsule
Artemisia 2 Capsule
(Double Potency)
BM Capsule
Capillaris Combination
Circulation P Capsule
Copmine Formula
Coptis Capsule
Cordyceps Capsule
DH-Artemisinin Capsule
Gall Formula 1
Gineseng and Atractylodes Formula
Glycyrrhizin Capsule
GL2
Hepa Formula 1A
Hepa Formula 2
HerbLipido
HerbSom Capsule
HerbZac Capsule
HH Tablets
HH 2 Capsule
(Double Potency)
Ligustrin Capsule
Milk Thistle Plus
MVM Formula
Olivessence Capsule
Puerarin Capsule
R-5081 Capsule
R-OBG Capsule
Schisandra Plus
Sedin
TGP formula
Yunan Paiyao Capsule
 
ZHANG CLINIC Hepatitis C Protocol:

Click here for HCV General Information Section


 Treatment Objectives
Anti-Fibrosis Treatment:
Control of Liver Inflammation and Normalization of Liver
Functions
Regulation of Immunity: Reducing Immunopathic Liver Damage
Enhance Liver Tissue Microcirculation to Promote Liver Tissue Regeneration
Facilitating Bile Secretion and Excretion

 
Hepatitis C:
Main Combination Protocols
Group 1
Hepa Formula 2         
Glycyrrhizin
Contraindicated for Patients with Hypertension
Ligustrin
Circulation P
Group 2
Hepa Formula 2         
Milk Thistle P
Ligustrin
Circulation P

 

Anti-Fibrosis Protocol:
Control of Liver Inflammation

ALT and AST elevation is an indication of liver cell damage or necrosis. The degree of elevation can also represent the severity of the liver inflammation. Chronic liver inflammation leads to cell necrosis and scar tissue formation (fibrosis). Generally, ALT and AST are good indicators for liver inflammation. Once inflammation is reduced, the progression of liver fibrosis can be held.

Back to Top
Formulas:

Hepa Formula 2 (Group 1)
Ligustrin (Group 1)
Milk Thistle P  (Group 2)
Hepa Formula 1A (Second-Line)
 
Regulation of Immunity: Reducing Immunopathic Liver Damage

HCV causes cytopathic and immunopathic damage to the liver. Immunopathology is the main pathology in chronic hepatitis. It causes globulinemia, cryoglobulinemia, rashes, joint pain and swelling, and many hepatitis-related autoimmune complications, such as diabetes, thyroid gland inflammation, Sjogren's syndrome, psoriasis, arthritis, and vasculitis. Regulating immunity includes suppressing overactive humeral immunity (reducing anti-body production, especially auto-antibody production), promoting CD8 cell function, and removing the circulatory immune complex (CIC) deposition in the liver, skin, and joints. 

Regulating immunity is an important precondition of normalizing liver function and lowering the HCV load. Suppressing auto-immunity is especially important for chronic active hepatitis.

Back to Top
Formulas:

Glycyrrhizin Capsule (Group 1)
AI # 3 Capsule (Individualized)

Cordyceps Capsule (Individualized)
Enhance Liver Tissue Microcirculation to Promote Liver Tissue Regeneration

The majority of patients with chronic liver disease exhibit poor blood circulation, especially microcirculation (smaller transport vessels and capillaries). 
According to Chinese Medicine principles, this is known as blood stagnancy. When microcirculation deteriorates, liver tissue does not receive proper nutrition and oxygen, which can exacerbate ongoing liver fibrosis. Improving microcirculation will help control fibrosis and promote liver tissue regeneration.

Back to Top
Formula:

Circulation P (Group 1 and Group 2)
Facilitating Bile Secretion and Excretion

Bile retention can injure the liver, promote fibrosis, and cause jaundice. In blood tests, bile retention is indicated by a rise in GGT, AKP (alkaline phosphatese), and bilirubin levels. About 50% of chronic hepatitis patients develop gallstones and chronic gallbladder inflammation.
Therefore, facilitating bile secretion is an important aspect of overall treatment.


Back to Top
Formula:

Gall Formula 1 (Individualized)